| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Institute of Endocrine Science (S.C., A.L., M.P., E.B., A.S.) and Endocrine Surgery (L.V.), Ospedale Maggiore IRCCS, Milan, Italy 20122
Address all correspondence and requests for reprints to: Anna Spada, M.D., Institute of Endocrine Science, Via F. Sforza, 35, 20122 Milan, Italy. E-mail . anna.spada{at}unimi.it
Abstract
The calcium-sensing receptor (CaR) activation has recently been shown to modulate the ERK1 and ERK2 cascade in different cell lines. The present study investigated this pathway in human normal and tumoral parathyroid cells. In cells from normal parathyroids and almost all hyperplasia increasing extracellular calcium concentrations (Cao2+) induced a significant activation of ERK1 and -2, the percent stimulation over basal activity (at 0.5 mM Cao2+) being 545 ± 140 and 800 ± 205 in normal cells and 290 ± 71 and 350 ± 73 in hyperplasia at 1 and 2 mM Cao2+, respectively. This effect was mediated by CaR because it was mimicked by the receptor agonist gadolinium and neomycin. Basal and Cao2+-stimulated ERK1 and -2 activity was nearly abolished by the PKC inhibitor calphostin C, and PKA changes did not affect ERK1 and -2 activity. PI3K blockade by wortmannin, known to prevent G protein ß
subunit effect on ERK1 and -2, induced a 30% reduction of the Cao2+-stimulated ERK1 and -2 activity. Adenomatous cells showed high PKC-dependent ERK1 and -2 activity in resting conditions that was unresponsive to high Cao2+. A role of MAPK on PTH secretion was suggested by the finding that PD98059, a specific MEK inhibitor, abolished the inhibitory effect of 1.5 mM Cao2+ on PTH release from normal parathyroid cells. In conclusion, these data first demonstrate that CaR activation, through the PKC pathway and, to a lesser extent, PI3K, increases ERK1 and -2 activity in normal parathyroid cells and this cascade seems to be involved in the modulation of PTH secretion by Cao2+. Interestingly, this signaling pathway is disrupted in parathyroid tumors.
This article has been cited by other articles:
![]() |
S. Corbetta, M. Belicchi, F. Pisati, M. Meregalli, C. Eller-Vainicher, L. Vicentini, P. Beck-Peccoz, A. Spada, and Y. Torrente Expression of Parathyroid-Specific Genes in Vascular Endothelial Progenitors of Normal and Tumoral Parathyroid Glands Am. J. Pathol., September 1, 2009; 175(3): 1200 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Parisi, Y. Almaden, M. Ibarz, S. Panizo, A. Cardus, M. Rodriguez, E. Fernandez, and J. M. Valdivielso N-methyl-D-aspartate receptors are expressed in rat parathyroid gland and regulate PTH secretion Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1291 - F1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Saidak, R. Mentaverri, and E. M. Brown The Role of the Calcium-Sensing Receptor in the Development and Progression of Cancer Endocr. Rev., April 1, 2009; 30(2): 178 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mamillapalli, J. VanHouten, W. Zawalich, and J. Wysolmerski Switching of G-protein Usage by the Calcium-sensing Receptor Reverses Its Effect on Parathyroid Hormone-related Protein Secretion in Normal Versus Malignant Breast Cells J. Biol. Chem., September 5, 2008; 283(36): 24435 - 24447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zanglis, D. Andreopoulos, and N. Baziotis Influence of L-Thyroxine Therapy on Parathyroid Hormone Concentrations Clin. Chem., June 1, 2008; 54(6): 1092 - 1093. [Full Text] [PDF] |
||||
![]() |
N. Makita, J. Sato, K. Manaka, Y. Shoji, A. Oishi, M. Hashimoto, T. Fujita, and T. Iiri An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations PNAS, March 27, 2007; 104(13): 5443 - 5448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pidasheva, M. Grant, L. Canaff, O. Ercan, U. Kumar, and G. N. Hendy Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly Hum. Mol. Genet., July 15, 2006; 15(14): 2200 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mittelman, G. N. Hendy, R. A. Fefferman, L. Canaff, I. Mosesova, D. E. C. Cole, L. Burkett, and M. E. Geffner A Hypocalcemic Child with a Novel Activating Mutation of the Calcium-Sensing Receptor Gene: Successful Treatment with Recombinant Human Parathyroid Hormone J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2474 - 2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Corbetta, L Vicentini, S Ferrero, A Lania, G Mantovani, D Cordella, P Beck-Peccoz, and A Spada Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors Endocr. Relat. Cancer, December 1, 2005; 12(4): 929 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ohanian, K. M. Gatfield, D. T. Ward, and V. Ohanian Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1756 - H1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukhopadhyay, H. G. Munshi, S. Kambhampati, A. Sassano, L. C. Platanias, and M. S. Stack Calcium-induced Matrix Metalloproteinase 9 Gene Expression Is Differentially Regulated by ERK1/2 and p38 MAPK in Oral Keratinocytes and Oral Squamous Cell Carcinoma J. Biol. Chem., August 6, 2004; 279(32): 33139 - 33146. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kifor, I. Kifor, F. D. Moore Jr., R. R. Butters Jr., T. Cantor, P. Gao, and E. M. Brown Decreased Expression of Caveolin-1 and Altered Regulation of Mitogen-Activated Protein Kinase in Cultured Bovine Parathyroid Cells and Human Parathyroid Adenomas J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4455 - 4464. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Hendy, C. Minutti, L. Canaff, S. Pidasheva, B. Yang, Z. Nouhi, D. Zimmerman, C. Wei, and D. E. C. Cole Recurrent Familial Hypocalcemia Due to Germline Mosaicism for an Activating Mutation of the Calcium-Sensing Receptor Gene J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3674 - 3681. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wada and N. Nagano Control of parathyroid cell growth by calcimimetics Nephrol. Dial. Transplant., March 1, 2003; 18(90003): iii13 - 17. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |